| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $1.67 (Miss by $-0.05) |
| EPS GAAP Actual | $1.67 (Miss by $-0.05) |
| Revenue Actual | $2.9735B |
| Revenue Surprise | Beat by $2973.5M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.74224 |
| EPS GAAP Estimate | $0.74224 |
| Revenue Estimate | $2.509579608B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 8.05 | 6.32 | 7.87158 | 8.21413 | 3 |
| Dec 2028 | 7.57 | 6.72 | 7.45701 | 7.73283 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -14.79 | -16.62515 | 2.9735B | -2.33% | -307.11M |
| FQ2 2025 (Jun 2025) | 2.14 | 2.14 | 3.2008B | -1.61% | 3200.8M |
| FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 2.3041B | -12.69% | 2304.1M |
| FQ4 2024 (Dec 2024) | 1.4 | 1.4 | 2.7356B | -2.02% | 2735.6M |
| FQ3 2024 (Sep 2024) | 3.88 | 3.88 | 3.0427B | -8.4% | 3042.7M |
| FQ2 2024 (Jun 2024) | 2.03 | 2.03 | 3.2523B | -0.44% | 3252.3M |
| FQ1 2024 (Mar 2024) | 0.98 | 0.98 | 2.5964B | 9.63% | 2596.4M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 2.7908B | 5.78% | 2790.8M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.74224
Consensus Revenue Estimates
2.509579608B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.362 | -- | 1.31174 | 1.40225 | 8 |
| FQ3 2027 (Sep 2027) | 2.1267 | -- | 2.04823 | 2.18954 | 8 |
| FQ2 2027 (Jun 2027) | 2.1482 | -- | 2.06894 | 2.21168 | 8 |
| FQ1 2027 (Mar 2027) | 0.7585 | -- | 0.73051 | 0.78091 | 8 |
| FQ4 2026 (Oct 2026) | 1.98473 | -- | 1.94511 | 2.08588 | 7 |
| FQ3 2026 (Jul 2026) | 1.92791 | 867.15 | 1.88942 | 2.02616 | 4 |
| FQ2 2026 (Jun 2026) | 1.95731 | -9.33 | 1.91133 | 2.01445 | 4 |
| FQ1 2026 (Mar 2026) | 0.74224 | 19.16 | 0.7248 | 0.76391 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.81B | -- | 2.73B | 2.87B | 6 |
| FQ3 2027 (Sep 2027) | 3.14B | -- | 3.05B | 3.22B | 3 |
| FQ2 2027 (Jun 2027) | 3.32B | -- | 3.23B | 3.4B | 3 |
| FQ1 2027 (Mar 2027) | 2.53B | -- | 2.46B | 2.59B | 3 |
| FQ4 2026 (Oct 2026) | 3.3B | -- | 3.25B | 3.43B | 4 |
| FQ3 2026 (Jul 2026) | 3.3B | 9.9 | 3.25B | 3.43B | 4 |
| FQ2 2026 (Jun 2026) | 3.35B | 4.34 | 3.29B | 3.42B | 4 |
| FQ1 2026 (Mar 2026) | 2.51B | 8.19 | 2.46B | 2.57B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.83515 | -14.79 | -16.62515 | 112.41% |
| FQ2 2025 (Jun 2025) | 2.14 | 2.14 | 100% | |
| FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 100% | |
| FQ4 2024 (Dec 2024) | 1.4 | 1.4 | 100% | |
| FQ3 2024 (Sep 2024) | 3.88 | 3.88 | 100% | |
| FQ2 2024 (Jun 2024) | 2.03 | 2.03 | 100% | |
| FQ1 2024 (Mar 2024) | 0.98 | 0.98 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.28B | $2.97B | $-307.11M | -10.33% |
| FQ2 2025 (Jun 2025) | $0B | $3.2B | $3200.8M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.3B | $2304.1M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.74B | $2735.6M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.04B | $3042.7M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.25B | $3252.3M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.6B | $2596.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.79B | $2790.8M | 100% |